Target Price: RM0.350, RM0.380 Last closing price: RM0.270 Potential return: 11.1%, 14.8% Support: RM0.255 Stop Loss: RM0.240 Possible for bottom fishing. TDM is staging a recovery from its downtrend. The price movement was well-supported following minor pullback from a surge on 7 June 2018. Improving RSI and MACD indicators currently signal reasonable entry level, with anticipation of continuous improvement in both momentum and trend in near term. Should resistance level of RM0.300 be broken, it may continue to lift price higher to subsequent resistance level of RM0.310.
(TDM 2054) is a plantation and hospital management company. In the first quarter of 2018, the company turned from profit to loss. Its revenue increased by 2.2%, but it turned from profit to loss. The pretax loss was 1.87 million, or 0.17 sen per share loss (3 months). The main reason for the loss was because the average price of palm oil fell from 3,200 to 2,400. Although the output has increased, it is still not enough to make up for the huge drop. The company’s management costs have also risen significantly, although in part because of the one-time costs associated with the opening of new hospitals, many other management costs have also increased. In this quarter, we can see that the company's hospital business has grown significantly. The rise in hospital beds and the collection of medical expenses have also increased. This upward trend should continue. On the other hand, in the planting business, since the price of oil palm is still low, and the palm oil business still accounts for most of the company’s revenue, it is believed that there will be no major breakthrough in performance in the coming quarter (net asset 63sen). (If you want to buy an index of 2 and a half stars, the company's performance is not good, but the hospital's business has a significant growth, while the price of palm oil, although sluggish but long-term good, so the company has the opportunity to reverse performance in the second half) 佳隆发展（TDM 2054），是一间种植和医院经营公司。公司2018年第一季度表现由盈转亏，其营收增加2.2%，但却由盈转亏，税前亏损为187万，或每股亏损（3个月）0.17sen。亏损的主因是因为棕油的平均价格从3200下跌至2400，虽然产量有增加，但还是不足以弥补巨大的落差。公司的管理成本也很明显的上升，虽然部分是因为新医院开张而产生一次性的费用，但还有许多其他管理成本也上升。在这个季度我们可以看见公司的医院业务有显著的成长，皆因病床增加且收取医药费用也所上升，而这个上升趋势应该会持续。反观在种植业务上，由于油棕价格还是偏低，而棕油业务还是占公司的大部分营收，所以未来的季度相信业绩不会有太大的突破（净资产63sen） （想买指数2星半，公司的业绩虽然不好，但医院的业务有显著的成长，而棕油的价格虽然低迷不过长期看好，所以公司有机会在下半年反转业绩的表现）